Andrew Zolopa, MD

Global Medical Director
ViiV Healthcare
Research Triangle Park, North Carolina, United States

GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)

Presentation(s):

• 75 - High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study

  On Demand